https://www.selleckchem.com/products/bi-d1870.html
The clot burden was significantly reduced compared to both tPA and a saline control (p less then 0.0001). We also tested the efficacy of all agents on red fibrinous clots formed in stagnant conditions. DiNAC did not lyse red clots, whereas tPA significantly lysed red clot over 48 h (p less then 0.01). These results lead to a novel use for DiNAC as a possible thrombolytic agent against acute arterial occlusions that could mitigate the risk of hyper-fibrinolytic bleeding.Premature mortality and undernutrition rates in Pakistan are among
Kao
Komentar
Udio
